Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Remus Pharmaceuticals IPO.
November 13, 2024 3:30:00 AM
is chairman and is the company secretary for Remus Pharmaceuticals Ltd. Bitcoin rallies to historic highs near $100,000 amid optimism for Donald Trump’s pro-crypto policies Niva Bupa IPO shares ...
Published by : Business TodayNovember 13, 2024 1:29:00 PM
The stock symbol for Remus Pharmaceuticals is "REMP." ...
Published by : InvestingOctober 30, 2024 8:12:00 PM
Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited as a private limited company, vide Certificate of Incorporation dated September 21, 2015 ...
Published by : India InfolineJune 4, 2024 4:30:00 AM
The Remus Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ?2536.65 today. What is the Market Cap of Remus Pharmaceuticals Ltd? Market capitalization, short for market cap ...
Published by : India InfolineThe IPO Shares of Remus Pharmaceuticals Limited IPO are proposed to list on Monday, May 29, 2023 at NSE SME. The public issue of Remus Pharmaceuticals IPO was opened on May 17, 2023 and closed for subscription on May 19, 2023. Remus Pharmaceuticals IPO Listing Date and Information:
| Listing Date | Monday, May 29, 2023 |
| BSE Script Code | |
| NSE Symbol | REMUS |
| Listing In | |
| ISIN | INE0O5T01011 |
| Issue Price | ₹1229 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
The allotment status of Remus Pharmaceuticals Limited IPO is now available online. The public issue of Remus Pharmaceuticals IPO was open on May 17, 2023 and closed for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME
.
Remus Pharmaceuticals Limited is entering in the capital market with an IPO of 388,000 Equity Shares of Rs 10 aggregating up to Rs 47.69 Crore. The price for the issue has been set at Rs 1150 - Rs 1229 Per Equity Share.
Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.
The issue opens on May 17, 2023 and closes for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME.
The issue of Remus Pharmaceuticals Limited opens on May 17, 2023 and closes for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 1150 - Rs 1229 Per Equity Share.
The Remus Pharmaceuticals IPO is proposed to open on May 17, 2023. The IPO application ends on May 19, 2023.
Retail investors can apply in the retail or non-institutional investor category from May 17, 2023 to May 19, 2023. The Remus Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Remus Pharmaceuticals IPO will open for subscription on May 17, 2023. The public issue will close on May 19, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
